Figure 6.
Prophylactic 6-ECDCA administration prevents progression to CKD after an I/R induced AKI episode. (A) Urinary albumin/creatinine ratios measured every 4 wk after surgery in sham and I/R groups. (B) Urinary albumin, (C) Kim1 and (D) H2O2 levels from different treatment groups. n = 6 mice/group. Data are means ± SEM, one-way ANOVA with Bonferroni’s test. *p < 0.05. (E) Representative images of PAS staining (scale bar 25 μm). (F-H) Representative images of (F) Masson’s trichrome staining and immunostaining for (G) αSMA and (H) collagen I in renal sections from (a) sham, (b) I/R and (c) I/R + ECDCA groups (scale bar 100 μm). αSMA and collagen I are localized in the tubulointerstitial spaces as markers for tubulointerstitial fibrosis. (I and J) Bars represent quantitative analysis of the (I) mesangial area and (J) fibrosis area per high power field. (K and L) Bars represent (K) TGF-β and (L) collagen I mRNA levels in the kidneys. n = 6 mice/group. Data are means ± SEM, one-way ANOVA with Bonferroni’s test. *p < 0.05.
